Aidoc, an Israeli medtech startup that develops healthcare solutions using artificial intelligence AI, raised $110 million in a Series D round investment led by investors TCV and Alpha Intelligence Capital (AIC). Aidoc has now raised a total of $250 million in funding to date.
Founded in 2016 by its CEO Elad Walach, CTO Michael Braginsky, and VP of R&D and CISO Guy Reiner, Aidoc is a provider of artificial intelligence healthcare solutions that empower physicians to expedite patient treatment and enhance operational capabilities. Aidoc’s AI Care Platform—the first of its kind—offers health systems a singular platform solution that works with physicians to manage the entire patient lifecycle—from diagnostic aid, to consultation to suggested treatment paths to patient follow-up tools.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at firstname.lastname@example.org.
The Aidoc founders are all graduates of the IDF’s Talpiot program. This is a special program for recruits who excelled in the sciences when in school. Talpiot allows such service men and women to put their scientific skills to use while serving in the military and also study for higher degrees at the same time.
Aidoc’s products assist clinicians by assessing CT scans for positive findings and prioritizing patients in need of immediate medical attention. Aidoc’s artificial intelligence-enabled software diagnoses a variety of acute medical disorders, including cerebral hemorrhage, stroke, pulmonary embolisms, and c-spine fractures. The software operates in the background, alongside the radiologist, informing and activating physicians as they move through the imaging procedure.
“We are building the kind of breadth and depth in AI that is allowing hospitals to fundamentally change the way they do business and provide the solutions needed to successfully compete during these challenging times” says Elad Walach, CEO of Aidoc. “Aidoc is already the leading imaging AI platform, but with this new round of investment, our aim is to massively ramp up our AI Care Platform to cover both the various hospital medical service lines and the depth of integration into the clinical workflows, empowering hospitals to activate cross-specialty care teams and deliver the best quality of care in a scalable, efficient way to patients.”